Literature DB >> 7713931

Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc.

L Bazar1, D Meighen, V Harris, R Duncan, D Levens, M Avigan.   

Abstract

A far upstream element (FUSE) of c-myc stimulates promoter activity when bound by a newly identified trans-acting protein, which is expressed in cycling cells. Since FUSE binding protein (FBP) binds only the noncoding strand (NCS) of its regulatory element in a sequence-specific manner, and not double-stranded (ds) DNA, formation of the protein DNA complex in vivo first requires unwinding of the DNA helix. In this report, we show evidence that FBP forces strand separation of short stretches of linear dsDNA. Because FUSE is contained within a region of helical instability that is partially unwound in negatively supercoiled DNA, it is a target for more extensive duplex strand separation by FBP, which first exposes and then selectively binds its NCS cognate sequence. In contrast, other single-stranded DNA binding proteins (SSBs) do not demonstrate this FUSE targeting activity. The novel linkage of regional dsDNA melting with cis-element binding by a transcriptional activator has broad implications in the regulation of eukaryotic gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713931     DOI: 10.1074/jbc.270.14.8241

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.

Authors:  L He; J Liu; I Collins; S Sanford; B O'Connell; C J Benham; D Levens
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  WEB-THERMODYN: Sequence analysis software for profiling DNA helical stability.

Authors:  Yanlin Huang; David Kowalski
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Transcription factor binding and induced transcription alter chromosomal c-myc replicator activity.

Authors:  M Ghosh; G Liu; G Randall; J Bevington; M Leffak
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

5.  Differential binding of replication proteins across the human c-myc replicator.

Authors:  Maloy Ghosh; Michael Kemp; Guoqi Liu; Marion Ritzi; Aloys Schepers; Michael Leffak
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.

Authors:  Juhong Liu; Fedor Kouzine; Zuqin Nie; Hye-Jung Chung; Zichrini Elisha-Feil; Achim Weber; Keji Zhao; David Levens
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

7.  Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.

Authors:  Kazuyuki Matsushita; Hideaki Shimada; Yasuji Ueda; Makoto Inoue; Mamoru Hasegawa; Takeshi Tomonaga; Hisahiro Matsubara; Fumio Nomura
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

8.  Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo.

Authors:  G A Michelotti; E F Michelotti; A Pullner; R C Duncan; D Eick; D Levens
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Characterization of the DNA-binding domain of the avian Y-box protein, chkYB-2, and mutational analysis of its single-strand binding motif in the Rous sarcoma virus enhancer.

Authors:  A Nambiar; S K Swamynathan; J C Kandala; R V Guntaka
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 10.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.